| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 06/24/2010 | WO2010069504A1 (3-oxo)pyridin-4-ylurea derivatives as pde4 inhibitors |
| 06/24/2010 | WO2010038086A3 P38 map kinase inhibitors |
| 06/24/2010 | WO2010038085A3 P38 map kinase inhibitors |
| 06/24/2010 | WO2010005958A3 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 06/24/2010 | US20100160405 Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dione |
| 06/24/2010 | US20100160371 Inhibition of p38 kinase activity by aryl ureas |
| 06/24/2010 | US20100160370 Method of treatment and pharmaceutical compositions |
| 06/24/2010 | US20100160366 Treatment method |
| 06/24/2010 | US20100160357 Heterobicyclic sphingosine 1-phosphate analogs |
| 06/24/2010 | US20100160347 PYRIDO[1,2-a]PYRIMIDIN-4-ONE INHIBITORS OF MAST CELL DEGRANULATION |
| 06/24/2010 | US20100160344 Novel compounds |
| 06/24/2010 | US20100160343 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 06/24/2010 | US20100160341 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 06/24/2010 | US20100160316 Quinazolines useful as modulators of ion channels |
| 06/24/2010 | US20100160271 Bicyclic modulators of h1 receptors |
| 06/24/2010 | US20100160254 Cellulose Sulfate for the Treatment of Rhinovirus Infection |
| 06/24/2010 | US20100160253 Sulphated xylans for treatment or prophylaxis of respiratory diseases |
| 06/24/2010 | US20100160230 Ubiquitin and ubiquitin related molecules for treatment and prevention of harmful activation of the immune system |
| 06/24/2010 | US20100160225 Lefty, lefty derivatives and uses thereof |
| 06/24/2010 | US20100160218 Airway Administration of Tissue Factor Pathway Inhibitor in Inflammatory Conditions Affecting the Respiratory Tract |
| 06/24/2010 | US20100159034 Pyrrolidinone inhibitors of pde-4 |
| 06/24/2010 | US20100158990 Transdermal method and patch for corticosteroid administration |
| 06/24/2010 | US20100158988 Cereal beta glucan compositions, methods of preparation and uses thereof |
| 06/24/2010 | US20100158987 Adhesive Label With Bittering Agent and Fluidifying Agents for Natural Airway Secretions |
| 06/24/2010 | US20100158941 Compositions and Methods for Treating Microbial Infections |
| 06/24/2010 | US20100158914 Klotho beta |
| 06/24/2010 | US20100158906 Use of recombinant monoclonal antibody with specific binding activity for cell surface phosphorylated glycoprotein in diagnosis and treatment of immune, cell proliferative and inflammatory disorders |
| 06/24/2010 | US20100158877 Treatment of lung and pulmonary diseases and disorders |
| 06/24/2010 | US20100158819 Calcium Glycerophosphate for Treating and Preventing Respiratory Diseases or Conditions |
| 06/24/2010 | DE102008063046A1 Medizinische Verwendung des ribosomalen Protein S19 (RPS19) Medical use of the ribosomal protein S19 (RPS19) |
| 06/24/2010 | CA2745459A1 Thiazoles as cannabinoid receptor ligands |
| 06/24/2010 | CA2745290A1 Thiadiazole-substituted arylamides |
| 06/24/2010 | CA2744888A1 Cysteine protease inhibitors |
| 06/24/2010 | CA2737335A1 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases |
| 06/23/2010 | EP2199284A1 Pharmaceutical composition for inhibiting accumulation of amyloid- beta protein |
| 06/23/2010 | EP2198877A2 Orally administered peptides to ameliorate atherosclerosis |
| 06/23/2010 | EP2198867A1 Pyrimidine-based compounds useful as GSK-3 inhibitors |
| 06/23/2010 | EP2198723A1 Inflammation inhibiting compounds |
| 06/23/2010 | EP2197551A1 Soluble guanylate cyclase activators |
| 06/23/2010 | EP2197494A2 Functionalized nanoparticles for the inhibition of selectin-mediated cell adhesion |
| 06/23/2010 | EP2197477A2 Use of lvv-hemorphin-6 and optionally af12198 as therapeutic agent(s) |
| 06/23/2010 | EP2197470A2 Use of bubuc and optionally eaa-mart1 (26-35) as a therapeutic agent for the treatment of hcmv infections |
| 06/23/2010 | EP2197466A2 Use of retrocyclin-1 as a therapeutic agent for the treatment of hcmv infections |
| 06/23/2010 | EP2197462A2 Use of il-1 receptor peptide, alone or in combination with d-ala-gln-octadecyl ester, as a therapeutic agent |
| 06/23/2010 | EP2197442A1 Polo-like kinase inhibitors |
| 06/23/2010 | CN1883566B Anti-inflammation medicine and method for preparing same |
| 06/23/2010 | CN101747432A Method for preparing alpha 1-antitrypsin medicine |
| 06/23/2010 | CN101745103A Normal-temperature preserved albumin preparation |
| 06/23/2010 | CN101745094A Medical application of MyD88 topological peptide compounds used as immunosuppressant |
| 06/23/2010 | CN101745060A Chinese medicament for treating chronic bronchitis |
| 06/23/2010 | CN101745045A Food having therapeutic action to diseases of prostate gland and containing Chinese herbal medicines |
| 06/23/2010 | CN101745044A Chinese material medica preparation for treating nasosinusitis |
| 06/23/2010 | CN101745041A Chinese medicine prescription for treating nosebleed |
| 06/23/2010 | CN101744985A Medicament for treating child repetitive respiratory infection and low immunity |
| 06/23/2010 | CN101744984A Formula for treating cough |
| 06/23/2010 | CN101744983A Chinese medicine prescription for treating acute pharyngitis |
| 06/23/2010 | CN101744946A Chinese medicinal composition and detection method for Chinese medicinal composition preparation |
| 06/23/2010 | CN101744930A Chinese medicinal atomizing preparation for treating chronic bronchitis |
| 06/23/2010 | CN101744920A Fingerprint control method for Jian'er Qinjie oral solution |
| 06/23/2010 | CN101744905A Applications of Chinese medicinal composition to preparation of medicament for treating pulmonary heart disease |
| 06/23/2010 | CN101744887A Detection Method for Chinese medicinal composition preparation |
| 06/23/2010 | CN101744870A Drug for prevention of atypical pneumonia |
| 06/23/2010 | CN101744868A Application of semen astragali complanati general flavone extractives in the preparation of pulmonary fibrosis prevention drugs |
| 06/23/2010 | CN101744854A Xiaoaiping pill and preparing method thereof |
| 06/23/2010 | CN101744849A Glabrous sarcandra herb dripping pill and preparation technology |
| 06/23/2010 | CN101744843A Method for design traditional Chinese medicine formulas and application thereof |
| 06/23/2010 | CN101744836A Pediatric paracetamol, atificial cow-bezoar and chlorphenamine maleate orally disintegrating tablet preparation and preparing method thereof |
| 06/23/2010 | CN101744820A Medicine composite containing dextromethorphan hydrobromide |
| 06/23/2010 | CN101744782A Tablet containing faropenem sodium |
| 06/23/2010 | CN101744774A Method for preparing ginkgolide B lyophilized powder injection |
| 06/23/2010 | CN101249117B Method for extracting flavonoid from Sarcopyramis nepalensis Wall |
| 06/23/2010 | CN101199696B Umbilical powder patch for treating rhinitis |
| 06/23/2010 | CN101181543B Chinese medicine composition orally taken for curing chronic bronchitis |
| 06/23/2010 | CN101129911B Medicine for treating deficiency of the lung gas weakness cough and chronic trachitis, and preparation method thereof |
| 06/23/2010 | CN101129822B Orally taken traditional Chinese medicine composition for treating bronchiolectasis |
| 06/23/2010 | CN101100689B Method for preparing pearl active peptide |
| 06/23/2010 | CN101085194B Internal-applied traditional Chinese medicine composition for treating asthma |
| 06/23/2010 | CN101062103B Olive soft capsule raw material formulation and its preparation technology |
| 06/22/2010 | US7741483 2-[2-ethoxyl-5-(4-ethylpiperazinyl-1-sulfonyl)phenyl]-5-methyl-7-n-propyl-3,7-dihydropyrrolo[2,3-d]pyrimidin-4-one, used for the treatment and/or prevention of sexual disorders such as erectile dysfunction |
| 06/22/2010 | US7741452 produced by introducing amino acid mutation(s) so that no glycosylation take place at at least one glycosylation site of hepatocyte growth factor; more stable in the blood circulation |
| 06/22/2010 | US7741434 High-affinity antagonists of ELR-CXC chemokines |
| 06/22/2010 | US7741338 mixtures comprising a polyene macrolide antibiotic and an antioxidant such as 2,6-di-tert.-butyl-4-methylphenol, that improves the stability of the polyene macrolide to oxidation |
| 06/22/2010 | US7741331 Use treating atherosclerosis, angiogenesis, type II diabetes, diabetic retinopathy, cancer, and asthma; for example, 3-ethyl-1-propyl-8-(1-[(3-trifluoromethylphenyl)methyl]pyrazol-4-yl)-1,3,7-trihydropurine-2,6-dione |
| 06/22/2010 | US7741330 1-((S)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)pyrrolidin-1-yl)-2,3-dihydroxypropan-1-one, used for the treatment of autoimmune diseases, inflammatory diseases, allergy disorders, B-cell proliferative disorders, or thromboembolic disorders |
| 06/22/2010 | US7741329 such as 1-{(S)-2-[(5-Bromo-pyrimidin-2-ylamino)-methyl]-piperidin-1-yl}-1-quinolin-2-yl-methanone, used as human orexin receptor antagonist, for the treatment of obesity and insomnia |
| 06/22/2010 | US7741328 Treating inflammatory diseases such as rheumatoid arthritis, multiple sclerosis or Crohn's disease; Very Late Antigen-4 (VLA-4), also called alpha 4 beta 1 integrin; N-(sulfonamido-substituted pyrimidyl, pyridyl or pyrazyl)-L-4-(N,N-dimethylcarbamyloxy)phenylalanine compounds |
| 06/22/2010 | US7741312 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries |
| 06/22/2010 | US7741278 Modified proteins, designer toxins, and methods of making thereof |
| 06/22/2010 | US7741076 developing genetic constructs capable of expressing lipidated rP6 in e coli; used for to preventing disease caused by Haemophilus influenzae |
| 06/22/2010 | US7740854 Treatment of macrophage mediated disease |
| 06/22/2010 | US7740853 Fcepsilon-pe chimeric protein for targeted treatment of allergy responses a method for its production and pharmaceutical compositions containing the same |
| 06/22/2010 | US7740851 Ultra high affinity neutralizing antibodies |
| 06/22/2010 | US7740842 comprising an E25 anti-IgE antibody and acetic acid ; nasal sprays and slow release formulations drying or freeze-drying; treating an allergic disease |
| 06/22/2010 | US7740834 Murine zcytor17 ligand polypeptides |
| 06/22/2010 | US7740831 Compositions for potentiating glutathione |
| 06/22/2010 | CA2688614A1 Phenyl-butoxy-phenyl-ethynyl substituted indole compounds having cyslt1/cyslt2 receptor antagonistic activity |
| 06/22/2010 | CA2586538C Nitroxy steroids |
| 06/22/2010 | CA2549672C Antineutrophilia agent using 3(2h)-pyridazinone compounds |
| 06/22/2010 | CA2495875C Process for producing metered dose inhaler formulations |
| 06/22/2010 | CA2480409C Novel pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy |